Literature DB >> 31853820

Apical variant hypertrophic cardiomyopathy "multimodality imaging evaluation".

Gary Huang1, Shaimaa A Fadl2, Stan Sukhotski3,4, Manuela Matesan3,4.   

Abstract

Apical variant hypertrophic cardiomyopathy (AHCM) is characterized by asymmetric hypertrophy of the left ventricular (LV) apex. T wave inversions of variable degree, particularly in the left precordial leads, and left ventricular hypertrophy (LVH) are common EKG findings in AHCM. Echocardiography is typically the initial imaging modality used in the diagnosis and evaluation of AHCM. The diagnosis is made when the LV apex has apical wall thickness of ≥ 15 mm or a ratio of apical to basal LV wall thickness of ≥ 1.3 at end-diastole. The use of microbubble contrast agents with echocardiography is helpful for visualization of the apex. Cardiac magnetic resonance (CMR) has the advantage of a large field of view and the ability to perform tissue characterization. Late gadolinium enhancement (LGE) sequences are essential in the assessment of potential areas of myocardial scarring. Cardiac computed tomography (CCT) has the advantage of being able to evaluate coronary arteries in addition to assessing cardiac anatomy and function. A "Solar Polar" map pattern is the characteristic feature of AHCM on myocardial perfusion imaging (MPI) in cases not associated with apical aneurysm (APA). Recognition of typical perfusion patterns in AHCM patients is not only important in the diagnostic evaluation of this disease process, but also for avoiding unnecessary and costly tests. The purpose of this article is to review the imaging features of AHCM from different imaging modalities and assess the value added of each modality in the diagnosis of AHCM.

Entities:  

Keywords:  Apical; Apical variant hypertrophic cardiomyopathy; CT; Echo; Myocardial hypertrophy; PET/CT; Radiology

Mesh:

Year:  2019        PMID: 31853820     DOI: 10.1007/s10554-019-01739-x

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  55 in total

1.  Severe ischaemia on SPECT myocardial perfusion imaging secondary to microvascular dysfunction and apical hypertrophic cardiomyopathy.

Authors:  Robert R Russo; Louise Emmett; Robert Mansberg; Kevin C Fung
Journal:  Clin Nucl Med       Date:  2010-12       Impact factor: 7.794

2.  Incidental detection of apical hypertrophic cardiomyopathy by myocardial perfusion imaging.

Authors:  Richard Bruce Irwin; Parthiban Arumugam; Rajdeep S Khattar
Journal:  Nucl Med Commun       Date:  2010-04       Impact factor: 1.690

3.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Roberto M Lang; Luigi P Badano; Victor Mor-Avi; Jonathan Afilalo; Anderson Armstrong; Laura Ernande; Frank A Flachskampf; Elyse Foster; Steven A Goldstein; Tatiana Kuznetsova; Patrizio Lancellotti; Denisa Muraru; Michael H Picard; Ernst R Rietzschel; Lawrence Rudski; Kirk T Spencer; Wendy Tsang; Jens-Uwe Voigt
Journal:  J Am Soc Echocardiogr       Date:  2015-01       Impact factor: 5.251

4.  Two- and three-dimensional speckle tracking echocardiography: clinical applications and future directions.

Authors:  Monodeep Biswas; Selvin Sudhakar; Navin C Nanda; Gerald Buckberg; Manish Pradhan; Asad Ullah Roomi; Willem Gorissen; Helene Houle
Journal:  Echocardiography       Date:  2013-01       Impact factor: 1.724

Review 5.  Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging.

Authors:  Iacopo Olivotto; Franco Cecchi; Corrado Poggesi; Magdi H Yacoub
Journal:  Circ Heart Fail       Date:  2012-07-01       Impact factor: 8.790

6.  Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity.

Authors:  Hua Yang; Anna Woo; Daniel Monakier; Michal Jamorski; Katie Fedwick; E Douglas Wigle; Harry Rakowski
Journal:  J Am Soc Echocardiogr       Date:  2005-10       Impact factor: 5.251

7.  Occasionally increased 18F-fluorodeoxyglucose uptake in apical hypertrophic cardiomyopathy with mid-ventricular obstruction.

Authors:  Hideya Yamamoto; Toshiro Kitagawa; Hitoshi Susawa; Ryoichiro Hata; Fuminari Tatsugami; Toru Higaki; Kazuo Awai; Yasuki Kihara
Journal:  J Cardiol Cases       Date:  2017-05-02

8.  Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States.

Authors:  Hiroaki Kitaoka; Yoshinori Doi; Susan A Casey; Nobuhiko Hitomi; Takashi Furuno; Barry J Maron
Journal:  Am J Cardiol       Date:  2003-11-15       Impact factor: 2.778

9.  An Uncommon Variant of an Uncommon Disease: A Caucasian Adolescent with Apical Hypertrophic Cardiomyopathy Diagnosed with Myocardial Perfusion Imaging.

Authors:  Rami Kassem Zein; Zaid Al-Faham; Jason A Mouabbi; Edouard R Daher
Journal:  World J Nucl Med       Date:  2017 Jul-Sep

10.  Cardiac MR Imaging of Hypertrophic Cardiomyopathy: Techniques, Findings, and Clinical Relevance.

Authors:  Yasuo Amano; Mitsunobu Kitamura; Hitoshi Takano; Fumi Yanagisawa; Masaki Tachi; Yasuyuki Suzuki; Shinichiro Kumita; Morimasa Takayama
Journal:  Magn Reson Med Sci       Date:  2018-01-18       Impact factor: 2.471

View more
  1 in total

1.  Cardiovascular imaging 2019 in the International Journal of Cardiovascular Imaging.

Authors:  Johan H C Reiber; Gabriel T R Pereira; Luis A P Dallan; Hiram G Bezerra; Johan De Sutter; Arthur E Stillman; Nico R L Van de Veire; Joachim Lotz
Journal:  Int J Cardiovasc Imaging       Date:  2020-05       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.